tradingkey.logo

BioNexus Gene Lab Corp

BGLC

6.595USD

+0.125+1.93%
Horarios del mercado ETCotizaciones retrasadas 15 min
11.85MCap. mercado
PérdidaP/E TTM

BioNexus Gene Lab Corp

6.595

+0.125+1.93%
Más Datos de BioNexus Gene Lab Corp Compañía
BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
Información de la empresa
Símbolo de cotizaciónBGLC
Nombre de la empresaBioNexus Gene Lab Corp
Fecha de salida a bolsaMar 11, 2020
Director ejecutivoMr. Lee Su-Leng Tan
Número de empleados30
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 11
Dirección10-2 Tower B, Vertical Business Suite
CiudadKUALA LUMPUR
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísMalaysia
Código postal59200
Teléfono13072416898
Sitio Webhttps://www.bionexusgenelab.com/
Símbolo de cotizaciónBGLC
Fecha de salida a bolsaMar 11, 2020
Director ejecutivoMr. Lee Su-Leng Tan
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
--
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Ping Lin Chai
Mr. Ping Lin Chai
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
--
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
CEC Science and Innovation Co., Ltd
11.13%
Liew (Choong-Chin)
9.28%
Lai (Soo Kow(kenny))
6.96%
Leong (Chi Yuen (George))
6.80%
Hai (Wong Kim)
5.80%
Other
60.03%
Accionistas
Accionistas
Proporción
CEC Science and Innovation Co., Ltd
11.13%
Liew (Choong-Chin)
9.28%
Lai (Soo Kow(kenny))
6.96%
Leong (Chi Yuen (George))
6.80%
Hai (Wong Kim)
5.80%
Other
60.03%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
39.98%
Corporation
11.13%
Hedge Fund
0.75%
Investment Advisor/Hedge Fund
0.13%
Other
48.01%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
23
934.06K
51.99%
+197.45K
2025Q1
24
939.06K
52.27%
+197.45K
2024Q4
23
9.20M
51.32%
+1.52M
2024Q3
19
7.99M
44.45%
+1.58M
2024Q2
20
11.44M
64.50%
+1.77M
2024Q1
20
11.47M
64.70%
+1.86M
2023Q4
19
9.88M
56.10%
+604.96K
2023Q3
14
9.57M
59.98%
+192.18K
2023Q2
9
9.37M
64.75%
+10.50K
2023Q1
9
9.36M
64.67%
--
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
CEC Science and Innovation Co., Ltd
200.00K
11.13%
+200.00K
--
Jan 22, 2024
Liew (Choong-Chin)
166.67K
9.28%
--
--
Feb 27, 2025
Lai (Soo Kow(kenny))
125.00K
6.96%
--
--
Feb 27, 2025
Leong (Chi Yuen (George))
122.21K
6.8%
+5.54K
+4.75%
Feb 27, 2025
Hai (Wong Kim)
104.25K
5.8%
+14.17K
+15.73%
Feb 27, 2025
Wong (Chan Chong)
103.14K
5.74%
--
--
Feb 27, 2025
Lim (Wei Foong)
36.29K
2.02%
--
--
Dec 31, 2024
Citadel Advisors LLC
9.88K
0.55%
+9.88K
--
Mar 31, 2025
Two Sigma Investments, LP
3.55K
0.2%
+3.55K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
2.37K
0.13%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI